Skip to content
IGM Biosciences
About Us
Our Company
Leadership Team
IGM Platform
Our IGM Platform
Publications
Presentations
Pipeline & Programs
Pipeline
Imvotamab
IGM-2644
Investors & News
Join Us
Our Culture
Open Jobs
Contact Us
<
Back to Publications
June 2021
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants
Nature, June 3, 2021
Download PDF
Offsite Link